HMGA2
MIM.600698 12q14-q15
Pathology
truncated HMGA2 isoforms
12q14 (HMGA2) rearrangements in tumors
- pulmonary chondroid hamartoma
- lipoma (16133369)
- pleomorphic salivary adenoma (9484777)
- uterine leiomyoma
- vaginal leiomyoma (17654722)
- myelodyplasia
- benign mesenchymoma (chondrolipoangioma) (12021922)
aggressive angiomyxoma of the lower genital tract (33%) (16990720, 17654722)
- t(8;12) (11550285)
- t(1;12)(p32;q15) (17654722)
- t(12;21)(q15;q21.1) (18295664)
pulmonary chondroid hamartoma (44.7%) (14621194)
- t(12;14)(q14;q24) (12699895)
- t(3;12)(q27;q14) (HMGA2/LPP fusion gene) (12505264, 16271958, 11890997)
HMGA2/NFIB fusion gene in
HMGA2/FHIT in a pleomorphic adenoma of the parotid gland (8988031)
bisruption and aberrant expression of HMGA2 by chromosomal translocations in myeloid malignancies (15618963)
- myelodyplasia
- HMGA2/RDC1 fusion protein expression in lipomas as the result of chromosome aberrations involving 2q35-37 and 12q13-15. (Fusion of RDC1 with HMGA2 in lipomas)
constitutional rearrangement of HMGA2 in a phenotype including extreme somatic overgrowth, advanced endochondral bone and dental ages, a cerebellar tumor, and multiple lipomas (15593017)
HMGA2 amplification in 12q13-15 amplification (12q13-15 amplicon) (18214854)
HMGA2 was identified as one of target genes of the let-7 family of miRNAs and has been found to be suppressed by let-7 in vitro. (17243163)
References
Italiano A, Bianchini L, Keslair F, Bonnafous S, Cardot-Leccia N, Coindre JM, Dumollard JM, Hofman P, Leroux A, Mainguené C, Peyrottes I, Ranchere-Vince D, Terrier P, Tran A, Gual P, Pedeutour F. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer. 2008 Jan 23; PMID: 18214854
Rabban JT, Dal Cin P, Oliva E. HMGA2 rearrangement in a case of vulvar aggressive angiomyxoma. Int J Gynecol Pathol. 2006 Oct;25(4):403-7. PMID: 16990720
Dal Cin P, Thomas A, Weremowicz S. An intragenic rearrangement of HMGA2 is not necessary for lipoma formation. Cancer Genet Cytogenet. 2004 Mar;149(2):178-9. PMID: 15036898
Dahlen A, Mertens F, Rydholm A, Brosjo O, Wejde J, Mandahl N, Panagopoulos I. Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol. 2003 Nov;16(11):1132-40. PMID: 14614053
Pentimalli F, Dentice M, Fedele M, Pierantoni GM, Cito L, Pallante P, Santoro M, Viglietto G, Dal Cin P, Fusco A. Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2. Cancer Res. 2003 Nov 1;63(21):7423-7. PMID: 14612541
Quade BJ, Weremowicz S, Neskey DM, Vanni R, Ladd C, Dal Cin P, Morton CC. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15. Cancer Res. 2003 Mar 15;63(6):1351-8. PMID: 12649198
Van Dorpe J, Dal Cin P, Weremowicz S, Van Leuven F, de Wever I, Van den Berghe H, Fletcher CD, Sciot R. Translocation of the HMGI-C ( HMGA2) gene in a benign mesenchymoma (chondrolipoangioma). Virchows Arch. 2002 May;440(5):485-90. PMID: 12021922
Kazmierczak B, Dal Cin P, Sciot R, Van den Berghe H, Bullerdiek J. Inflammatory myofibroblastic tumor with HMGIC rearrangement. Cancer Genet Cytogenet. 1999 Jul 15;112(2):156-60. PMID: 10686944